July 02, 2019
Slideshow
What does compensation for neurologists look like these days? Would you choose neurology all over again?
June 07, 2019
Article
Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.
April 18, 2019
Article
Chronic pain, sleep disorders, neuropathy, and anxiety were the most common conditions that showed improvement in the study.
October 25, 2017
Article
Do you want to make your voice heard? Then join the Neurology Times Advisory Board!